When The Gut Speaks, The Brain Listens: The Love Language of Microbiome and Mind

Abstract

The gut–brain axis (GBA) comprises a two-way communication system between the gastrointestinal system and the central nervous system. The system consists of neural, endocrine, immune, and metabolic pathways, and provides the ability of the gut and brain to communicate at all times. The GBA facilitates communication between the gut and brain and regulates physiological and psychological functions. The vagus nerve acts as a major pathway that transmits signals from the gut microbiota to the brain, while the enteric nervous system (ENS) responds to central and peripheral signaling to regulate intestinal motility and secretions. Gut microbiota, which consists of trillions of microorganisms, plays an essential role in this communication. Gut microbiota synthesizes neuroactive molecules such as serotonin, gamma-aminobutyric acid (GABA), dopamine, and short-chain fatty acids (SCFAs), which all have an influence on cognition, mood, and stress response. Gut dysbiosis, or an imbalance of gut microbial composition, has been observed to lead to psychiatric and neurodevelopmental disorders including, but not limited to, depression, autism spectrum disorder, schizophrenia, and anxiety. In patients with depression, gut dysbiosis is typically associated with reduced microbial diversity and lower levels of Lactobacillus, Bifidobacterium, and other beneficial bacteria.

Keywords

Introduction

The gut-brain axis (GBA) is a two-way communication network that contains neural, endocrine, and immune pathways that connect the central nervous system (CNS) to the gastrointestinal (GI) tract1. This sophisticated system permits the brain to impact gut behaviors such, as motility, secretion, and immune activation, while the signals housed in the gut can influence mood, cognition, and behavior2. Recent studies point toward the gut microbiome, which consists of trillions of microorganisms housed in the human gut, as an important regulator of this communication3. Changes in the composition of the gut microbiome, termed dysbiosis, have been implicated in the pathophysiology of a number of psychiatric and neurological disorders, including depression, anxiety, autism spectrum disorders, and schizophrenia4. Gaining insights into the gut brain axis mechanisms is particularly relevant to assessing novel therapeutic options. Interventions such as prebiotics, probiotics, dietary modification, and fecal microbiota transplantation (FMT) may prove helpful in the restoration of microbial balance and improvement in mental health outcomes. While research in this area is expanding, most literature is correlational, and causation is often difficult to establish5,6. Thus, the purpose of our review is to investigate the specific mechanisms of the gut microbiome and brain relationship, assess implications for mental health disorders, and consider some psychoactive therapeutics that target the microbiota gut–brain axis for the promotion of psychological health.

MECHANISMS OF GUT–BRAIN COMMUNICATION

The GBA operates through interconnected pathways, including neuro-immune and endocrine systems7,8. First, the vagus nerve represents the primary neural pathway from the gut to the brain. The vagus nerve transmits afferent sensory information from the wall of the intestine to the brainstem, which can then influence emotional and behavioral reactions9. Certain metabolites made by gut microbes, such as spinal chain fatty acids (SCFAs), can trigger vagal afferent information, impacting brain regions involved in mood regulation10. The immune system pathway involves signals from gut microbes in various ways to impact systemic inflammatory responses. Dysbiosis may affect intestinal permeability, leading to translocation of microbial products such as lipopolysaccharide (LPS), which stimulates systemic release of pro-inflammatory cytokines11. Elevated levels of cytokines may pass through the blood–brain barrier, which can alter neurotransmission in the brain and contribute to depressive and anxious symptoms12. An endocrine pathway is also important, as the gut microbiota may also impact hormone production of hypothalamic–pituitary–adrenal (HPA) stress axis13. In addition, microbes are capable of producing or influencing important neurotransmitters such as serotonin, gamma-aminobutyric acid (GABA), and dopamine that can help regulate mood and emotion14.

GUT MICROBIOTA AND MENTAL HEALTH

Evidence is increasing that the gut microbiota significantly affects mental health through regulation of brain chemistry, immune response, and inflammation signaling pathways15. Research involving germ-free mice demonstrates that the absence of gut microbes is associated with extreme responses to stress, altered levels of neurotransmitters, such as serotonin and GABA, and dysregulation of behavior that can be reversed by microbial colonization16. Similarly, fecal microbiota transplantation (FMT) from depressed humans into animals is shown to induce behavior similar to depression, which effectively confirms microbiome influence in regulating mood17. Research on humans suggests that individuals with anxiety and depression show evidence of lower richness and diversity of microbes, and altered levels of beneficial genera, such as Lactobacillus and Bifidobacterium18. Changes in the gut microbiota may disrupt a number of neuroactive compounds and also cause signals for systemic inflammation for a variety of mood disorders. In addition, alterations in the gut microbiota can increase activation of the hypothalamic-pituitary-adrenal (HPA) axis and proinflammatory cytokines which can all increase distress. Although the exact functional causal mechanisms remain to be fully elucidated, evidence suggests there is a strong rationale for concluding that gut microbial dysbiosis contributes to the onset and development of depression, anxiety, and other psychiatric diagnosis19.

DIET, PROBIOTICS, AND LIFESTYLE FACTORS

Food is stepping forward to become a defining aspect of the gut microbiome and thereby brain functioning20. Diets high in fiber, plant-based foods, and fermented foods tend to support the survival of good bacteria and maintain production of the Short Chain Fatty Acids (SCFAs) that support gut barrier function and lower inflammation21. On the other hand, Western-style diets that are high in saturated fat and processed sugar tend towards dysbiosis and a greater rate of mood disorder22.Probiotics, or live microorganisms that provide a health benefit to the host, have been published on its psychobiotics effects, particularly as it relates to certain strains of Lactobacillus and Bifidobacterium, which have been shown to reduce depressive and anxiety symptoms in several clinical trials23. Prebiotics, which act as a substrate or food for beneficial microbes, provides the basis for gut microbial health and starts more indirectly support mental health24. However, variations between studies and probiotics strains demonstrate that there is a need for continued work toward a more uniform set of clinical trial guidelines25. Lifestyle factors, such as regular physical exercise, effective management of stress, and adequate sleep, also support a healthy microbiome. Chronic stress can alter the microbes that inhabit the gut as well as to regulate the HPA axis, contributing to mood disorders26.

FUTURE PERSPECTIVES AND RESEARCH DIRECTIONS

Although there have been significant advancements in understanding gut microbiome and mental health, establishing a causative link remains challenging. Most studies are correlational, and therefore, we do not currently know which gut microbiome composition causes which mental state or behavior. There are other confounding variables such as, but not limited to, diet, genetics, lifestyle, that may also produce these observed changes. Well-designed longitudinal and interventional human studies are absolutely needed to establish causal links between gut microbiome and mental health.

Results will open the door to possible new treatments focused on the gut microbiome for mental health27. The gut-brain axis must be examined through rigorous integrated multi- omics approaches in the future, including but not limited to metagenomics, metabolomics, transcriptomics, and neuroimaging, as it relates to gut-brain interactions taking place. These methods will allow researchers to describe microbial genes, metabolites, and relevant signaling pathways that influence neural function. Then, in combining omics data and brain imaging will allow for the visualization of structural and functional changes taking place in the brain as a result of changes in the gut microbiome. As noted above, though, studies utilizing an integrated approach provide a richer opportunity for a greater understanding of the molecular networks linking the microbiome to behavior and cognition. Additionally, including a longitudinal and intervention style will be of additional strength in determining causal pathways. Therefore, this approach will ultimately lead to developing precision microbiome-based therapies for mental health disorders28. While there is potential merit to personalized nutrition and microbiome-based therapeutics, each of these ideas will need to be thoroughly examined to better understand their impact on the microbiome, or mental health29.

CONCLUSION

The gut-brain axis has changed how we think about the relationship between the gut and mental health. Growing evidence suggests that gut microbiota affects brain function, mood and behavior through neural, immune, endocrine and metabolic pathways.

Microbial metabolites, such as short-chain fatty acids and compounds with neurotransmitter-like effects, also modify brain function and emotional well-being. Modulating the diet, probiotics, prebiotics or other lifestyle strategies might be useful, promising and feasible non-invasive treatments for mental health, especially in correcting the gut microbiome to promote balanced microflora. These approaches could function as innovative and personalized treatments in disorders including depression and anxiety.

Contemporary studies in this area remain predominately correlational, and currently it is not yet possible to establish causation resulting from an intervention. Future investigations should focus on longitudinal and interventional human studies that utilize multi-omics approaches such as metagenomics, metabolomics, and neuroimaging to elucidate mechanisms of action. This research would be further improved by including the microbiome composition and response to interventions in specific populations to develop precision-based treatments. Overall, the gut-brain axis has many intriguing opportunities to improve and better understand mental health disorders. Continued development in this areas may lead to safe, effective and personalized treatments targeting the microbiome establishing a connection to the gut and mental health.

REFERENCES

1. Verma A, Inslicht SS, Bhargava A. Gut-brain axis: Role of microbiome, metabolomics, hormones, and stress in mental health disorders. Cells. 2024 Aug 27;13(17):1436.
2. Clapp M, Aurora N, Herrera L, Bhatia M, Wilen E, Wakefield S. Gut microbiota’s effect on mental health: The gut-brain axis. Clinics and practice. 2017 Sep 15;7(4):987.
3. Sangal M. The gut-brain Axis: the effect of dysbiosis on mood disorders like anxiety and depression. Journal of High School Science. 2022 Nov 23;6(4).
4. Bertolín-Guillén JM. Microbiota-gut-brain axis and mental health. British Journal of Healthcare and Medical Research-Vol. 2023 Dec 25;10(6).
5. Ansari F, Neshat M, Pourjafar H, Jafari SM, Samakkhah SA, Mirzakhani E. The role of probiotics and prebiotics in modulating of the gut-brain axis. Front Nutr 10: 1173660 [Internet]. 2023
6. Settanni CR, Ianiro G, Bibbò S, Cammarota G, Gasbarrini A. Gut microbiota alteration and modulation in psychiatric disorders: Current evidence on fecal microbiota transplantation. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021 Jul 13;109:110258.
7. Foster JA, Neufeld KA. Gut–brain axis: how the microbiome influences anxiety and depression. Trends in neurosciences. 2013 May 1;36(5):305-12.
8. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature reviews neuroscience. 2012 Oct;13(10):701-12.
9. Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. The Journal of clinical investigation. 2015 Mar 2;125(3):926-38.
10. Rusch JA, Layden BT, Dugas LR. Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis. Frontiers in endocrinology. 2023 Jun 19;14:1130689.
11. Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Frontiers in cellular neuroscience. 2015 Oct 14;9:392.
12. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Progress in Neuro- Psychopharmacology and Biological Psychiatry. 2011 Apr 29;35(3):664-75.
13. Marwaha K, Cain R, Asmis K, Czaplinski K, Holland N, Mayer DC, Chacon J. Exploring the complex relationship between psychosocial stress and the gut microbiome: implications for inflammation and immune modulation. Journal of Applied Physiology. 2025 Feb 1;138(2):518-35.
14. Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015 Apr 9;161(2):264-76.
15. Dinan TG, Cryan JF. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. The Journal of physiology. 2017 Jan 15;595(2):489-503.
16. Heijtz RD, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S. Normal gut microbiota modulates brain development and behavior. Proceedings of the National Academy of Sciences. 2011 Feb 15;108(7):3047-52.
17. Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, Zeng L, Chen J, Fan S, Du X, Zhang X. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Molecular psychiatry. 2016 Jun;21(6):786-96.
18. Jiang HY, Zhang X, Yu ZH, Zhang Z, Deng M, Zhao JH, Ruan B. Altered gut microbiota profile in patients with generalized anxiety disorder. Journal of psychiatric research. 2018 Sep 1;104:130-6.
19. Kelly JR, Borre Y, O'Brien C, Patterson E, El Aidy S, Deane J, Kennedy PJ, Beers S, Scott K, Moloney G, Hoban AE. Transferring the blues: depression- associated gut microbiota induces neurobehavioural changes in the rat. Journal of psychiatric research. 2016 Nov 1;82:109-18.
20. Dash S, Clarke G, Berk M, Jacka FN. The gut microbiome and diet in psychiatry: focus on depression. Current opinion in psychiatry. 2015 Jan 1;28(1):1-6.
21. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014 Jan 23;505(7484):559-63.
22. Jacka FN, Pasco JA, Mykletun A, Williams LJ, Hodge AM, O'Reilly SL, Nicholson GC, Kotowicz MA, Berk M. Association of Western and traditional diets with depression and anxiety in women. American journal of psychiatry. 2010 Mar 1;167(3):305-11.
23. 21. Wallace CJ, Milev R. The effects of probiotics on depressive symptoms in humans: a systematic review. Annals of general psychiatry. 2017 Feb 20;16(1):14.
24. Schmidt K, Cowen PJ, Harmer CJ, Tzortzis G, Errington S, Burnet PW. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology. 2015 May;232(10):1793-801.
25. Romijn AR, Rucklidge JJ. Systematic review of evidence to support the theory of psychobiotics. Nutrition reviews. 2015 Oct 1;73(10):675-93.
26. Allen JM, Mailing LJ, Niemiro GM, Moore R, Cook MD, White BA, Holscher HD, Woods JA. Exercise alters gut microbiota composition and function in lean and obese humans. Med Sci Sports Exerc. 2018 Apr 1;50(4):747-57.
27. Cryan JF, O'Riordan KJ, Cowan CS, Sandhu KV, Bastiaanssen TF, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE. The microbiota-gut-brain axis. Physiological reviews. 2019 Aug 28.
28. Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The central nervous system and the gut microbiome. Cell. 2016 Nov 3;167(4):915-32.
29. Drlja?a J, Miloševi? N, Milanovi? M, Abenavoli L, Mili? N. When the microbiome helps the brain?current evidence. CNS Neuroscience & Therapeutics. 2023 Jun;29:43-58.